Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.7.11.2 (
PDK1
)
2,238
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The present study was undertaken to examine whether dichloroacetate, which inhibits
pyruvate dehydrogenase kinase
and, therefore, increases the activity of
pyruvate dehydrogenase
, attenuates myocardial acidosis and metabolic changes induced by coronary occlusion. In dogs anesthetized with pentobarbital, the left anterior descending coronary artery was incompletely occluded to reduce the left anterior descending flow to a half to one third of the original flow (partial occlusion) to produce myocardial (regional) ischemia. Partial occlusion was continued for 90 min, and a bolus injection of saline or dichloroacetate was made intravenously 30 min after the onset of occlusion. Partial occlusion decreased myocardial pH significantly. An injection of dichloroacetate (150 mg/kg) increased myocardial pH that had been lowered by partial occlusion. Myocardial metabolites were measured in other dogs. Partial occlusion decreased the myocardial levels of adenosine triphosphate, creatine phosphate and energy charge potential, and increased that of lactate significantly, without affecting the myocardial levels of pyruvate and nonesterified fatty acids. Dichloroacetate attenuated the ischemia-induced changes in the myocardial levels of adenosine triphosphate, creatine phosphate, energy charge potential and lactate. These results indicate that dichloroacetate attenuates the myocardial acidosis and metabolic changes during coronary partial occlusion.
...
PMID:Dichloroacetate attenuates myocardial acidosis and metabolic changes induced by partial occlusion of the coronary artery in dogs. 209 18
The activity of
pyruvate dehydrogenase
(
PDH
) complex and
PDH kinase
were measured in brown adipose tissue (BAT) of 4-week-gold thioglucose (GTG)-obese mice. The proportion of
PDH
complex in the active dephosphorylated form was 2-fold higher in BAT of post-absorptive obese mice compared with lean controls. This result was consistent with the higher circulating insulin concentration observed in GTG-obese mice. In both obese and lean mice the
PDH
-complex activity in BAT decreased after 24 h starvation and increased in response to supraphysiological insulin injection, indicating that the
PDH
complex is insulin-responsive in BAT of GTG-obese mice. There was no difference in the
PDH kinase
activity of BAT in post-absorptive or insulin-injected lean and obese mice, suggesting that the higher
PDH
-complex activity in obese mice was not due to decreased
PDH kinase
activity. There is no evidence for a decreased activity of
PDH
complex contributing to insulin resistance in BAT of 4-week-GTG-obese mice.
...
PMID:Pyruvate dehydrogenase-complex activity in brown adipose tissue of gold thioglucose-obese mice. 211 59
The increased activity of
pyruvate dehydrogenase
(
PDH
) kinase induced in hearts of rats by starvation for 48 h was maintained following preparation of cardiac myocytes, and it was also maintained, though at a decreased level, after 25 h of culture in medium 199. This loss of
PDH kinase
activity was not prevented by n-octanoate, dibutyryl cyclic AMP or glucagon. The
PDH kinase
activity of myocytes from fed rats was increased to that of starved rats after 25 h of culture with n-octanoate, dibutyryl cyclic AMP or both agents together.
...
PMID:Longer-term regulation of pyruvate dehydrogenase kinase in cultured rat cardiac myocytes. 215 9
Purified bovine heart
pyruvate dehydrogenase complex
was used to investigate the effects of monovalent cations and alpha-ketoisovalerate on
pyruvate dehydrogenase
(
PDH
) kinase inhibition by thiamin pyrophosphate. Initial velocity patterns for thiamin pyrophosphate inhibition were consistent with hyperbolic non-competitive or hyperbolic uncompetitive inhibition at various K+ concentrations between 0 and 120 mM. The Kis, Kid, and Kin for thiamin pyrophosphate were in the range of 0.009 to 5.1 microM over the range of K+ concentrations tested. In the absence of K+, 1 mM alpha-ketoisovalerate had no effect on
PDH kinase
inhibition by thiamin pyrophosphate, whereas in the presence of 20 mM K+, alpha-ketoisovalerate stimulated
PDH kinase
activity almost 2-fold over the range of 0-80 microM thiamin pyrophosphate. Half-maximal stimulation by alpha-ketoisovalerate occurred at about 200 microM in the presence of 100 microM thiamin pyrophosphate and 20 mM K+. Similar but less extensive changes occurred in the presence of 100 microM thiamin pyrophosphate and 1 mM NH4+. Initial velocity patterns for
PDH kinase
inhibition by thiamin pyrophosphate in the presence of 2 mM alpha-ketoisovalerate were mixed noncompetitive, but alpha-ketoisovalerate increased the Vm and Km for adenosine 5'-triphosphate in the presence of inhibitor. In the presence of thiamin pyrophosphate,
PDH kinase
remained stimulated after chromatography on Sephadex G-25 to remove alpha-ketoisovalerate. The results indicate that acylation of
pyruvate dehydrogenase complex
by alpha-ketoisovalerate results in
PDH kinase
stimulation but only in the presence of monovalent cations and thiamin pyrophosphate.
...
PMID:Bovine heart pyruvate dehydrogenase kinase stimulation by alpha-ketoisovalerate. 221 97
The effects of various metabolites on
pyruvate dehydrogenase
(
PDH
) kinase-catalyzed inactivation of the
pyruvate dehydrogenase complex
(
PDC
) were studied in extracts of mitochondria purified from green leaf tissue of Pisum sativum L. Pyruvate was an uncompetitive inhibitor of
PDH kinase
with respect to ATP whereas ADP was a competitive inhibitor. In the absence of pyruvate a fivefold excess of ADP over ATP was required to inhibit
PDH kinase
, however, in the presence of pyruvate much lower ADP concentrations were required. Inhibition of
PDH kinase
by pyruvate and ADP was synergistic and the addition of ADP changed pyruvate from an uncompetitive inhibitor to a noncompetitive inhibitor. This result indicates that pyruvate acts as a "dead-end" inhibitor, binding to the
PDH kinase
-ADP reaction intermediate. Evidence is also presented that inhibition by pyruvate in the presence of thiamine pyrophosphate is due to the formation of hydroxyethyl thiamine pyrophosphate. The results are discussed in terms of the regulation of
PDC
activity by pyruvate and ADP during periods of increased demand for carbon skeleton biosynthesis by way of the tricarboxylic acid (TCA) cycle despite constraints imposed on TCA cycle flux by a high ATP/ADP ratio.
...
PMID:Mechanism of pyruvate inhibition of plant pyruvate dehydrogenase kinase and synergism with ADP. 232 60
The activities of
pyruvate dehydrogenase
(
PDH
) kinase and of
PDH kinase
activator protein (KAP) were increased 2-2.4-fold during 25 h of culture of hepatocytes from fed rats with glucagon plus n-octanoate.
PDH kinase
activity in hepatocytes from starved rats (initially 2.2 x fed control) fell during 25 h of culture in medium 199 (to 1.5 x fed control), but was maintained by glucagon plus octanoate. Dibutyryl or 8-bromo cyclic AMP increased
PDH kinase
activity 2-2.2-fold in hepatocytes from fed rats, but phenylephrine and isoproterenol (isoprenaline) were without effect. Insulin blocked the action of glucagon to increase
PDH kinase
activity and decreased the effect of octanoate and octanoate plus glucagon. It is suggested that the effects of starvation to increase activities of
PDH kinase
and of KAP in liver are mediated by alterations in circulating concentrations of glucagon, fatty acids and insulin and in hepatic cyclic AMP.
...
PMID:Longer-term regulation of pyruvate dehydrogenase kinase in cultured rat hepatocytes. 253 88
The effect of cerebral ischemia on the activity of
pyruvate dehydrogenase
(
PDH
) enzyme complex (PDHC) was investigated in homogenates of frozen rat cerebral cortex following 15 min of bilateral common carotid occlusion ischemia and following 15 min, 60 min, and 6 h of recirculation after 15 min of ischemia. In frozen cortical tissue from the same animals, the levels of labile phosphate compounds, glucose, glycogen, lactate, and pyruvate was determined. In cortex from control animals, the rate of [1(-14)C]pyruvate decarboxylation was 9.6 +/- 0.5 nmol CO2/(min-mg protein) or 40% of the total PDHC activity. This fraction increased to 89% at the end of 15 min of ischemia. At 15 min of recirculation following 15 min of ischemia, the PDHC activity decreased to 50% of control levels and was depressed for up to 6 h post ischemia. This decrease in activity was not due to a decrease in total PDHC activity. Apart from a reduction in ATP levels, the acute changes in the levels of energy metabolites were essentially normalized at 6 h of recovery. Dichloroacetate (DCA), an inhibitor of
PDH kinase
, given to rats at 250 mg/kg i.p. four times over 2 h, significantly decreased blood glucose levels from 7.4 +/- 0.6 to 5.1 +/- 0.3 mmol/L and fully activated PDHC. In animals in which the plasma glucose level was maintained at control levels of 8.3 +/- 0.5 mumol/g by intravenous infusion of glucose, the active portion of PDHC increased to 95 +/- 4%. In contrast, the depressed PDHC activity at 15 min following ischemia was not affected by the DCA treatment.(ABSTRACT TRUNCATED AT 250 WORDS)
...
PMID:Pyruvate dehydrogenase activity in the rat cerebral cortex following cerebral ischemia. 271 7
The effects of monovalent ions on endogenous
pyruvate dehydrogenase
(
PDH
) kinase activity in purified bovine heart
pyruvate dehydrogenase complex
were investigated. Activity of
PDH kinase
was stimulated 1.9-, 1.95-, 1.65-, and 1.4-fold by 10 mM K+, Rb+, NH+4, and Cs+, respectively, whereas Na+ and Li+ had no effect on
PDH kinase
activity. The crystal radii of stimulatory ions were in the range of 1.33 to 1.69 A while the crystal radii of nonstimulatory ions were in the range of 0.6 to 0.94 A. Stimulation of
PDH kinase
by monovalent ions was not pH dependent. Protein dilution studies showed that monovalent ion stimulation was measurable within 10 s after protein addition to
PDH kinase
assays. Furthermore, stimulation occurred at all protein concentrations tested. At ATP concentrations from 12.5 to 25 microM, K+ and NH+4 stimulation was constant from 0 to 110 and 0 to 30 mM, respectively. At higher ATP concentrations, from 50 to 500 microM, K+ and NH+4 stimulation peaked at approximately 30 and 3 mM, respectively, and thereafter declined as the ion concentration increased. Maximal
PDH kinase
stimulation by K+ or NH+4 also declined as Na+ was increased from 0 to 120 mM, but at a fixed salt concentration of 120 mM, both K+ and NH+4 stimulated
PDH kinase
activity. Phosphopeptide analysis demonstrated that K+ and NH+4 stimulated phosphorylation at sites 1 and 2, but that site 3 phosphorylation was relatively constant under all conditions. Thiamin pyrophosphate and 5,5'-dithiobis-(2-nitrobenzoate) blocked monovalent ion stimulation half-maximally at 4 and 6 microM, respectively. However, neither thiamin pyrophosphate nor 5,5'-dithiobis-(2-nitrobenzoate) significantly inhibited
PDH kinase
activity in the absence of monovalent ions. The results indicate that heart
PDH kinase
stimulation by monovalent ions does not occur by changing the binding equilibrium between
PDH
and dihydrolipoyl transacetylase core. Instead, monovalent ions bind and exert their regulatory effects at or near the active site of
PDH kinase
.
...
PMID:Bovine heart pyruvate dehydrogenase kinase stimulation by monovalent ions. 274 10
The effect of thiamine triphosphate (ThTP) and thiamine diphosphate (ThDP) on the activity of rat liver
pyruvate dehydrogenase complex
regulatory enzymes (kinase and phosphatase) was studied in experiments with isolated enzyme preparations. It is shown that ThDP caused a pronounced activation of pyruvate dehydrogenase phosphatase (Ka is equal to 65.0 nM). ThTP inhibits phosphatase competitively against the substrate--the phosphorylated
pyruvate dehydrogenase complex
. The both thiamine phosphates inhibit the
pyruvate dehydrogenase kinase
activity almost similarly in concentrations exceeding 10 microM. The physiological significance of the antagonistic action of ThDP and ThTP on the pyruvate dehydrogenase phosphatase activity is discussed.
...
PMID:[Effect of thiamine phosphates on the activity of regulatory enzymes of the pyruvate dehydrogenase complex]. 282 86
The putative mediator of intracellular insulin action has been assayed quantitatively by its ability to increase the activity of solubilized
pyruvate dehydrogenase
(
PDH
) phosphatase. Conversion of soluble beef heart
PDH
b to
PDH
a by
PDH
phosphatase increased when incubation was carried out in the presence of a crude insulin mediator fraction generated from insulin-treated adipose tissue or liver plasma membranes. Increased
PDH
phosphatase activity was proportional to the concentration of added insulin mediator. Mediator generation was rapid, with a half-time of approximately 45 sec and was insulin dose dependent. Half-maximal mediator activity was produced at 0.3 nM added insulin, with maximal activity being generated at approximately 3 nM insulin. Mediator activity was significantly decreased at 7 nM insulin, but was increased 4-fold after ethanol extraction. Mediator behaved as an activator of
PDH
phosphatase, apparently by abolishing the inhibitory effects of ATP on phosphatase activity, but had no effect on
PDH kinase
activity. The assay of insulin mediator activity described here can be carried out under standardized conditions, in contrast to previously described methods using particulate mitochondrial preparations.
...
PMID:Assay of insulin mediator activity with soluble pyruvate dehydrogenase phosphatase. 298 64
<< Previous
1
2
3
4
5
6
7
8
9
10
Next >>